{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:47:20Z","timestamp":1788385640244,"version":"build-2803163510"},"reference-count":49,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,8,15]]},"abstract":"<jats:p>Gremlin is a member of the CAN (cerberus and DAN) family of secreted BMP (bone morphogenetic protein) antagonists and also an agonist of VEGF (vascular endothelial growth factor) receptor-2. It is critical in limb skeleton and kidney development and is re-expressed during tissue fibrosis. Gremlin binds strongly to heparin and heparan sulfate and, in the present study, we sought to investigate its heparin-binding site. In order to explore a putative non-contiguous binding site predicted by computational molecular modelling, we substituted a total of 11 key arginines and lysines located in three basic residue sequence clusters with homologous sequences from cerberus and DAN (differential screening selected gene abberative in neuroblastoma), CAN proteins which lack basic residues in these positions. A panel of six Myc-tagged gremlin mutants, MGR-1\u2013MGR-6 (MGR, mutant gremlin), each containing different combinations of targeted substitutions, all showed markedly reduced affinity for heparin as demonstrated by their NaCl elution on heparin affinity chromatography, thus verifying our predictions. Both MGR-5 and MGR-6 retained BMP-4-binding activity comparable to that of wild-type gremlin. Low-molecular-mass heparin neither promoted nor inhibited BMP-4 binding. Finally, glutaraldehyde cross-linking demonstrated that gremlin forms non-covalent dimers, similar behaviour to that of DAN and also PRDC (protein related to cerberus and DAN), another CAN protein. The resulting dimer would possess two heparin-binding sites, each running along an exposed surface on the second \u03b2-strand finger loop of one of the monomers.<\/jats:p>","DOI":"10.1042\/bj20150228","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T09:11:48Z","timestamp":1438852308000},"page":"53-64","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Mapping the heparin-binding site of the BMP antagonist gremlin by site-directed mutagenesis based on predictive modelling"],"prefix":"10.1042","volume":"470","author":[{"given":"Arnold\u00a0Junior","family":"Tatsinkam","sequence":"first","affiliation":[{"name":"Centre for Biomedical Sciences, Royal Holloway University of London, Egham Hill, Egham, Surrey TW20 0EX, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mulloy","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Sciences, Royal Holloway University of London, Egham Hill, Egham, Surrey TW20 0EX, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher\u00a0C.","family":"Rider","sequence":"additional","affiliation":[{"name":"Centre for Biomedical Sciences, Royal Holloway University of London, Egham Hill, Egham, Surrey TW20 0EX, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2015,8,6]]},"reference":[{"key":"2021112216220068300_B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20100305","article-title":"Bone morphogenetic proteins and growth differentiation factor cytokine families and their protein antagonists","volume":"429","author":"Rider","year":"2010","journal-title":"Biochem. J."},{"key":"2021112216220068300_B2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1042\/BST0340409","article-title":"Heparin\/heparan sulphate binding in the TGF-\u03b2 cytokine superfamily","volume":"34","author":"Rider","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"2021112216220068300_B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/me.2003-0227","article-title":"Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists","volume":"18","author":"Avsian-Kretchmer","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"2021112216220068300_B4","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"key":"2021112216220068300_B5","doi-asserted-by":"publisher","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112216220068300_B6","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1242\/dev.00674","article-title":"Wise, a context-dependent activator and inhibitor of Wnt signalling","volume":"130","author":"Itasaki","year":"2003","journal-title":"Development"},{"key":"2021112216220068300_B7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2012.06.035","article-title":"The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites","volume":"150","author":"Gao","year":"2012","journal-title":"Cell"},{"key":"2021112216220068300_B8","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1161\/ATVBAHA.111.235184","article-title":"Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin","volume":"31","author":"Chiodelli","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021112216220068300_B9","doi-asserted-by":"publisher","first-page":"10890","DOI":"10.1074\/jbc.M807994200","article-title":"Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation","volume":"284","author":"Veverka","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2021112216220068300_B10","doi-asserted-by":"publisher","first-page":"23159","DOI":"10.1074\/jbc.M109.025478","article-title":"Characterization of wise protein and its molecular mechanism to interact with both Wnt and BMP signals","volume":"284","author":"Lintern","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2021112216220068300_B11","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.str.2013.06.005","article-title":"Structure of protein related to Dan and Cerberus: insights into the mechanism of bone morphogenetic protein antagonism","volume":"21","author":"Nolan","year":"2013","journal-title":"Structure"},{"key":"2021112216220068300_B12","doi-asserted-by":"publisher","first-page":"8785","DOI":"10.1074\/jbc.275.12.8785","article-title":"Biosynthesis, post-translation modification, and functional characterisation of Drm\/gremlin","volume":"275","author":"Topol","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021112216220068300_B13","doi-asserted-by":"publisher","first-page":"23134","DOI":"10.1074\/jbc.M402376200","article-title":"Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation","volume":"279","author":"Sudo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021112216220068300_B14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/BJ20140771","article-title":"Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7","volume":"466","author":"Church","year":"2015","journal-title":"Biochem. J."},{"key":"2021112216220068300_B15","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1182\/blood-2010-06-291930","article-title":"Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2","volume":"116","author":"Mitola","year":"2010","journal-title":"Blood"},{"key":"2021112216220068300_B16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ng1178","article-title":"Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning","volume":"34","author":"Khokha","year":"2003","journal-title":"Nat. Genet."},{"key":"2021112216220068300_B17","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1242\/dev.01251","article-title":"Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis","volume":"131","author":"Michos","year":"2004","journal-title":"Development"},{"key":"2021112216220068300_B18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jcp.22730","article-title":"Gremlin 1 is required for skeletal development and postnatal skeletal homeostasis","volume":"227","author":"Canalis","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"2021112216220068300_B19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1210\/en.2004-0766","article-title":"Skeletal overexpression of gremlin impairs bone formation and causes osteopenia","volume":"146","author":"Gazzerro","year":"2005","journal-title":"Endocrinology"},{"key":"2021112216220068300_B20","doi-asserted-by":"publisher","first-page":"31549","DOI":"10.1074\/jbc.M701317200","article-title":"Conditional deletion of gremlin causes a transient increase in bone formation and bone mass","volume":"282","author":"Gazzerro","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021112216220068300_B21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000092453","article-title":"Recapitulation of embryological programmes in renal fibrosis - the importance of epithelial cell plasticity and developmental genes","volume":"103","author":"Roxburgh","year":"2006","journal-title":"Nephron Physiol."},{"key":"2021112216220068300_B22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2353\/ajpath.2006.051263","article-title":"Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis","volume":"169","author":"Koli","year":"2006","journal-title":"Am. J. Pathol."},{"key":"2021112216220068300_B23","doi-asserted-by":"publisher","first-page":"16289","DOI":"10.1074\/jbc.M600711200","article-title":"Transcriptional profiling reveals novel markers of liver fibrogenesis: gremlin and insulin-like growth factor-binding proteins","volume":"281","author":"Boers","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021112216220068300_B24","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1167\/iovs.07-0086","article-title":"The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy","volume":"48","author":"Lee","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2021112216220068300_B25","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1167\/iovs.06-0296","article-title":"Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma","volume":"48","author":"Wordinger","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2021112216220068300_B26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cardfail.2013.09.001","article-title":"Gremlin-1 identifies fibrosis and predicts adverse outcome in patients with heart failure undergoing endomyocardial biopsy","volume":"19","author":"Mueller","year":"2013","journal-title":"J. Cardiac Failure"},{"key":"2021112216220068300_B27","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2337\/db08-1365","article-title":"Allelic depletion of grem1 attenuates diabetic kidney disease","volume":"58","author":"Roxburgh","year":"2009","journal-title":"Diabetes"},{"key":"2021112216220068300_B28","doi-asserted-by":"publisher","first-page":"e11709","DOI":"10.1371\/journal.pone.0011709","article-title":"In\u00a0vivo delivery of gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7","volume":"5","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"2021112216220068300_B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2369-14-33","article-title":"Gremlin induces cell proliferation and extracellular matrix accumulation in mouse mesangial cells exposed to high glucose via the ERK1\/2 pathway","volume":"14","author":"Huang","year":"2013","journal-title":"BMS Nephrol."},{"key":"2021112216220068300_B30","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/jcb.24559","article-title":"Gremlin aggravates hyperglycemia-induced podocyte injury by a TGF\u03b2\/smad dependent signaling pathway","volume":"114","author":"Li","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"2021112216220068300_B31","doi-asserted-by":"publisher","first-page":"14842","DOI":"10.1073\/pnas.0606857103","article-title":"Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation","volume":"103","author":"Sneddon","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216220068300_B32","doi-asserted-by":"publisher","first-page":"e42264","DOI":"10.1371\/journal.pone.0042264","article-title":"Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells","volume":"7","author":"Mulvihill","year":"2012","journal-title":"PLoS One"},{"key":"2021112216220068300_B33","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.molonc.2013.04.002","article-title":"Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1","volume":"7","author":"Karagiannis","year":"2013","journal-title":"Mol. Oncol."},{"key":"2021112216220068300_B34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jmb.2012.10.003","article-title":"Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers","volume":"424","author":"Kattamuri","year":"2012","journal-title":"J. Mol. Biol."},{"key":"2021112216220068300_B35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1006\/cyto.1997.0246","article-title":"Characterisation of human recombinant interleukin 2 binding to heparin and heparan sulphate using an ELISA approach","volume":"9","author":"Najjam","year":"1997","journal-title":"Cytokine"},{"key":"2021112216220068300_B36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1042\/BJ20061747","article-title":"The major determinant of the heparin binding of glial cell-line derived neurotrophic factor is near the aminoterminus and is dispensable for receptor binding","volume":"404","author":"Alfano","year":"2007","journal-title":"Biochem. J."},{"key":"2021112216220068300_B37","doi-asserted-by":"publisher","first-page":"7351","DOI":"10.1093\/nar\/16.15.7351","article-title":"A general method of in\u00a0vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions","volume":"16","author":"Higuchi","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"2021112216220068300_B38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0378-1119(89)90358-2","article-title":"Site-directed mutagenesis by overlap extension using the polymerase chain reaction","volume":"77","author":"Ho","year":"1989","journal-title":"Gene"},{"key":"2021112216220068300_B39","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1093\/nar\/25.16.3371","article-title":"Rapid and efficient site-directed mutagenesis by single-tube \u2018megaprimer\u2019 PCR method","volume":"25","author":"Ke","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"2021112216220068300_B40","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1093\/nar\/25.11.2227","article-title":"A rapid and efficient method for site-directed mutagenesis using one-step overlap extension PCR","volume":"25","author":"Urban","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"2021112216220068300_B41","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1182\/blood-2006-06-032276","article-title":"Bone morphogenic protein antagonist Drm\/gremlin is a novel proangiogenic factor","volume":"109","author":"Stabile","year":"2007","journal-title":"Blood"},{"key":"2021112216220068300_B42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/08927020701784754","article-title":"Application of drug discovery software to the identification of heparin-binding sites on protein surfaces: a computational survey of the 4-helix cytokines","volume":"34","author":"Mulloy","year":"2008","journal-title":"Mol. Simulation"},{"key":"2021112216220068300_B43","doi-asserted-by":"publisher","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2021112216220068300_B44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0960-9822(01)00684-4","article-title":"Action range of BMP is defined by its N-terminal basic amino acid core","volume":"12","author":"Ohkawara","year":"2002","journal-title":"Curr. Biol."},{"key":"2021112216220068300_B45","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.str.2013.07.015","article-title":"TGF-\u03b2 antagonists: same knot, but different hold","volume":"21","author":"Hinck","year":"2013","journal-title":"Structure"},{"key":"2021112216220068300_B46","doi-asserted-by":"publisher","first-page":"22294","DOI":"10.1074\/jbc.M311224200","article-title":"Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in\u00a0vivo","volume":"279","author":"Lau","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021112216220068300_B47","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1074\/jbc.M114.628412","article-title":"Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists","volume":"290","author":"Nolan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"2021112216220068300_B48","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1158\/1078-0432.CCR-06-1520","article-title":"Vascular endothelial growth factor signaling pathways: therapeutic perspective","volume":"12","author":"Kowanetz","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"2021112216220068300_B49","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1074\/jbc.M109151200","article-title":"Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients","volume":"277","author":"Paine-Saunders","year":"2002","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/470\/1\/53\/684326\/bj4700053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/470\/1\/53\/684326\/bj4700053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T23:07:42Z","timestamp":1637622462000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/470\/1\/53\/48604\/Mapping-the-heparin-binding-site-of-the-BMP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,6]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20150228","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,6]]}}}